Home > National Drug Code (NDC) > Irbesartan and Hydrochlorothiazide

Irbesartan and Hydrochlorothiazide - 33342-058-06 - (Irbesartan and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Irbesartan and Hydrochlorothiazide

Product NDC: 33342-058
Proprietary Name: Irbesartan and Hydrochlorothiazide
Non Proprietary Name: Irbesartan and Hydrochlorothiazide
Active Ingredient(s): 12.5; 300    mg/1; mg/1 & nbsp;   Irbesartan and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Irbesartan and Hydrochlorothiazide

Product NDC: 33342-058
Labeler Name: Macleods Pharmaceuticals Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA202414
Marketing Category: ANDA
Start Marketing Date: 20120927

Package Information of Irbesartan and Hydrochlorothiazide

Package NDC: 33342-058-06
Package Description: 3 BLISTER PACK in 1 CARTON (33342-058-06) > 10 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of Irbesartan and Hydrochlorothiazide

NDC Code 33342-058-06
Proprietary Name Irbesartan and Hydrochlorothiazide
Package Description 3 BLISTER PACK in 1 CARTON (33342-058-06) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 33342-058
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Irbesartan and Hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20120927
Marketing Category Name ANDA
Labeler Name Macleods Pharmaceuticals Limited
Substance Name HYDROCHLOROTHIAZIDE; IRBESARTAN
Strength Number 12.5; 300
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Irbesartan and Hydrochlorothiazide


General Information